254 related articles for article (PubMed ID: 21450183)
1. Efficacy of oral extended-release oxybutynin in cognitively impaired older nursing home residents with urge urinary incontinence: a randomized placebo-controlled trial.
Lackner TE; Wyman JF; McCarthy TC; Monigold M; Davey C
J Am Med Dir Assoc; 2011 Nov; 12(9):639-47. PubMed ID: 21450183
[TBL] [Abstract][Full Text] [Related]
2. Randomized, placebo-controlled trial of the cognitive effect, safety, and tolerability of oral extended-release oxybutynin in cognitively impaired nursing home residents with urge urinary incontinence.
Lackner TE; Wyman JF; McCarthy TC; Monigold M; Davey C
J Am Geriatr Soc; 2008 May; 56(5):862-70. PubMed ID: 18410326
[TBL] [Abstract][Full Text] [Related]
3. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
Zellner M; Madersbacher H; Palmtag H; Stöhrer M; Bödeker RH;
Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997
[TBL] [Abstract][Full Text] [Related]
4. Does oxybutynin add to the effectiveness of prompted voiding for urinary incontinence among nursing home residents? A placebo-controlled trial.
Ouslander JG; Schnelle JF; Uman G; Fingold S; Nigam JG; Tuico E; Jensen BB
J Am Geriatr Soc; 1995 Jun; 43(6):610-7. PubMed ID: 7775717
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study.
MacDiarmid SA; Peters KM; Chen A; Armstrong RB; Orman C; Aquilina JW; Nitti VW
Mayo Clin Proc; 2008 Sep; 83(9):1002-10. PubMed ID: 18775200
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
Staskin DR; Dmochowski RR; Sand PK; Macdiarmid SA; Caramelli KE; Thomas H; Hoel G
J Urol; 2009 Apr; 181(4):1764-72. PubMed ID: 19233423
[TBL] [Abstract][Full Text] [Related]
7. A phase 2, randomized, double-blind, efficacy and safety study of oxybutynin vaginal ring for alleviation of overactive bladder symptoms in women.
Gittelman M; Weiss H; Seidman L
J Urol; 2014 Apr; 191(4):1014-21. PubMed ID: 24231837
[TBL] [Abstract][Full Text] [Related]
8. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
Khullar V; Hill S; Laval KU; Schiøtz HA; Jonas U; Versi E
Urology; 2004 Aug; 64(2):269-74; discussion 274-5. PubMed ID: 15302476
[TBL] [Abstract][Full Text] [Related]
9. Preliminary evaluation of a new controlled-release oxybutynin in urinary incontinence.
Radomski SB; Caley B; Reiz JL; Miceli PC; Harsanyi Z; Darke AC
Curr Med Res Opin; 2004; 20(2):249-53. PubMed ID: 15006020
[TBL] [Abstract][Full Text] [Related]
10. Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial.
Malone-Lee J; Shaffu B; Anand C; Powell C
J Urol; 2001 May; 165(5):1452-6. PubMed ID: 11342895
[TBL] [Abstract][Full Text] [Related]
11. A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence.
Davila GW; Daugherty CA; Sanders SW;
J Urol; 2001 Jul; 166(1):140-5. PubMed ID: 11435842
[TBL] [Abstract][Full Text] [Related]
12. Patient-selected goals in overactive bladder: a placebo controlled randomized double-blind trial of transdermal oxybutynin for the treatment of urgency and urge incontinence.
Cartwright R; Srikrishna S; Cardozo L; Robinson D
BJU Int; 2011 Jan; 107(1):70-6. PubMed ID: 20626389
[TBL] [Abstract][Full Text] [Related]
13. Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. The Ditropan XL Study Group.
Versi E; Appell R; Mobley D; Patton W; Saltzstein D
Obstet Gynecol; 2000 May; 95(5):718-21. PubMed ID: 10775736
[TBL] [Abstract][Full Text] [Related]
14. An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder.
Goldenberg MM
Clin Ther; 1999 Apr; 21(4):634-42. PubMed ID: 10363730
[TBL] [Abstract][Full Text] [Related]
15. Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. OROS Oxybutynin Study Group.
Anderson RU; Mobley D; Blank B; Saltzstein D; Susset J; Brown JS
J Urol; 1999 Jun; 161(6):1809-12. PubMed ID: 10332441
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence.
Dmochowski RR; Davila GW; Zinner NR; Gittelman MC; Saltzstein DR; Lyttle S; Sanders SW;
J Urol; 2002 Aug; 168(2):580-6. PubMed ID: 12131314
[TBL] [Abstract][Full Text] [Related]
17. Cizolirtine citrate is safe and effective for treating urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept study.
Zát'ura F; Vsetica J; Abadías M; Pavlík I; Schraml P; Brod'ák M; Villoria J; Sust M;
Eur Urol; 2010 Jan; 57(1):145-52. PubMed ID: 19446951
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: a randomized, double-blind, placebo-controlled study.
Goldfischer ER; Sand PK; Thomas H; Peters-Gee J
Neurourol Urodyn; 2015 Jan; 34(1):37-43. PubMed ID: 24133005
[TBL] [Abstract][Full Text] [Related]
19. Combined behavioral and individualized drug therapy versus individualized drug therapy alone for urge urinary incontinence in women.
Burgio KL; Goode PS; Richter HE; Markland AD; Johnson TM; Redden DT
J Urol; 2010 Aug; 184(2):598-603. PubMed ID: 20639023
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, parallel-group comparison of controlled- and immediate-release oxybutynin chloride in urge urinary incontinence.
Barkin J; Corcos J; Radomski S; Jammal MP; Miceli PC; Reiz JL; Harsanyi Z; Darke AC;
Clin Ther; 2004 Jul; 26(7):1026-36. PubMed ID: 15336467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
